A potential drawback of this method is the low yield, which may be attributable to the immunomagnetic-negative selection of CD45+ cells, since a partial loss of CTC was observed during that process in patients with colon cancer (Ausch et al, 2007). The gene discussed is PTPRC; the disease is colonic neoplasm.